N-acylethanolamines (NAEs) are bioactive lipids, structural analogues to the endocannabinoid arachidonoylethanolamide (anandamide), whose functions and properties are being elucidated in recent years. By activating their receptors, specifically peroxisome proliferator-activated receptors (PPARs), these molecules exert a variety of physiological effects via genomic and rapid non-genomic mechanisms. Regulation of lipid metabolism, energy homeostasis, and anti-inflammation are among the best-characterized effects of PPAR activation. NAEs are abundant in the CNS and their receptors are widely expressed both in neurons and in glial cells, where they modulate brain functions and are involved in the pathophysiology of neurological and psychiatric disorders. In the brain, they participate in the regulation of feeding behavior, cognitive functions, mood, reward, and sleep-wake cycles, and evidence suggests that they might be therapeutically exploited as neuroprotective agents, "anti-addictive" medications, anticonvulsant, and antidepressant. In this chapter, we will review the state of the art on these neuromodulators and their receptors in the brain and will discuss new hypotheses on their physiological and pathophysiological roles.

Roles of N-acylethanolamines in brain functions and neuropsychiatric diseases

Pistis M;Muntoni AL
2017

Abstract

N-acylethanolamines (NAEs) are bioactive lipids, structural analogues to the endocannabinoid arachidonoylethanolamide (anandamide), whose functions and properties are being elucidated in recent years. By activating their receptors, specifically peroxisome proliferator-activated receptors (PPARs), these molecules exert a variety of physiological effects via genomic and rapid non-genomic mechanisms. Regulation of lipid metabolism, energy homeostasis, and anti-inflammation are among the best-characterized effects of PPAR activation. NAEs are abundant in the CNS and their receptors are widely expressed both in neurons and in glial cells, where they modulate brain functions and are involved in the pathophysiology of neurological and psychiatric disorders. In the brain, they participate in the regulation of feeding behavior, cognitive functions, mood, reward, and sleep-wake cycles, and evidence suggests that they might be therapeutically exploited as neuroprotective agents, "anti-addictive" medications, anticonvulsant, and antidepressant. In this chapter, we will review the state of the art on these neuromodulators and their receptors in the brain and will discuss new hypotheses on their physiological and pathophysiological roles.
2017
Istituto di Neuroscienze - IN -
-
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/337248
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? ND
social impact